share_log

Needham Maintains Buy on Veracyte, Raises Price Target to $44

Needham Maintains Buy on Veracyte, Raises Price Target to $44

Needham维持对veracyte的买入评级,并将目标股价上调至44美元
Benzinga ·  2024/11/07 05:48  · 评级/大行评级

Needham analyst Mike Matson maintains Veracyte (NASDAQ:VCYT) with a Buy and raises the price target from $37 to $44.

Needham分析师Mike Matson维持对Veracyte(纳斯达克:VCYT)的买入评级,并将目标股价从37美元上调至44美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发